Browse studies, page 383
Page 383 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Adjuvant Therapy for Helicobacter pylori Eradication: Role of Lansoprazole Shown In Vitro Journal of Clinical Gastroenterology, 1995
- Comparative in Vitro Dissolution Assessment of Three Different Brands of Lansoprazole Capsules Research Journal of Pharmaceutical Dosage Forms and Technology, 2011
- Comparative evaluation of the concentration-dependent effect of proton-pump inhibitor in association with calcium hydroxide and chlorhexidine on Enterococcus faecalis: An in vitro study Journal of Oral and Maxillofacial Pathology, 2021
- Formulation and in vitro characterization of lansoprazole floating gastroretentive microspheres by modified non aqueous solvent evaporation method Der pharma chemica, 2010
- Formulation and in vitro evaluation of lansoprazole micropellets 2009
- Determination of 5-Hydroxylansoprazole/Lansoprazole Sulfone by HPLC-MS/MS in Incubation System in Vitro Zhōnghuá yàoxué zázhì, 2012
- Efficacy of various proton-pump inhibitors and calcium hydroxide as intracanal medicaments against Enterococcus Faecalis: An in vitro study Endodontology, 2022
- Study on the Correlation between Dissolution in Vitro and Absorption in Vivo of Lansoprazole Enteric-coated Tablets The Chinese Journal of Modern Applied Pharmacy, 2012
- Effect of Surfactants on Lansoprazole Solid Dispersions: A Pathway to Improved Dissolution and Development of Fast Disintegrating Tablets Journal of Neonatal Surgery, 2025
- Paeoniflorin alleviates necroptosis in acute kidney injury induced by cisplatin and lansoprazole through targeting TNFAIP3 International Immunopharmacology, 2025
- Formulation and in-vitro Evaluation of orodispersible Tablets of Lansoprazole Journal of Innovations in Pharmaceutical and Biological Sciences, 2015
- Formulation Development, Process Optimization, and In Vitro Characterization of Spray-Dried Lansoprazole Enteric Microparticles Scientia Pharmaceutica, 2015
- Omeprazole exacerbates intervertebral disc degeneration through Caspase-3 mediated apoptosis of nucleus pulposus cells: a Mendelian randomization, network toxicology, and in vitro experimental study Journal of Orthopaedic Surgery and Research, 2025
- Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay Scientific Reports, 2025
- Formulation and development of statistical optimization of gastro-retentive drug delivery system: in-vivo and in-vitro study International journal of engineering science and advanced technology, 2025
- In vitro-in vivo scaling of cytochrome P450-mediated metabolic clearance using a relative activity factor approach Drug Metabolism And Disposition, 2025
- Inhibition of Gastric H+,K+-ATPase Activity in Vitro by Dissolution Media of Original Brand-Name and Generic Tablets of Lansoprazole, a Proton Pump Inhibitor Chemical and pharmaceutical bulletin, 2018
- In vitro Evaluation of Gastro Retentive Drug Delivery System of Lansoprazole Research Journal of Pharmacy and Technology, 2019
- Forced degradation studies of lansoprazole using LC-ESI HRMS and 1 H-NMR experiments: in vitro toxicity evaluation of major degradation products Journal of Mass Spectrometry, 2017
- Formulation and In Vitro Evaluation of Bilayer Tablets of Lansoprazole and Amoxycillin Trihydrate for the Treatment of Peptic Ulcer Journal of Drug Delivery and Therapeutics, 2021
- Formulation, optimization, and in-vitro-ex-vivo evaluation of dual-crosslinked zinc pectinate-neem gum-interpenetrating polymer network mediated lansoprazole loaded floating microbeads International Journal of Biological Macromolecules, 2022
- In Vitro Drug-Drug Interaction of Metformin HCl with Omeprazole and Lansoprazole Journal of Hunan University Natural Sciences, 2024
- Development and In Vitro Characterization of Azadirachta Indica Gum Grafted Polyacrylamide Based pH‐Sensitive Hydrogels to Improve the Bioavailability of Lansoprazole Chemistry and Biodiversity, 2024
- Controlled release floating drug delivery system for proton pump inhibitors lansoprazole: In-vitro, In-vivo floating and pharmacokinetic evaluation Pakistan Journal of Pharmaceutical Sciences, 2022
- Heparin-Induced Hyperkalemia Assessment Utilizing the Naranjo Adverse Drug Reaction Probability Scale: A 40-Year Systematic Review Pharmacy (Basel, Switzerland), 2025
- Development of Ensemble Steric and Electrostatic Chirality (ESEC) descriptors for modelling chromatographic enantioseparations PloS one, 2025
- Post-transplant cyclophosphamide-induced cardiotoxicity: A comprehensive review Journal of cardiovascular and thoracic research, 2024
- Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review Journal of clinical medicine, 2020
- Inhibition of SARS-COV-2 Receptor-Binding domain/ACE2 by Bazedoxifene 2022
- Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer EClinicalMedicine, 2026
- Recurring Paralysis and a Race Against Time: A Case of Cauda Equina Syndrome With Delayed Diagnosis and Incomplete Neurological Recovery Cureus, 2025
- The microbiome of pseudomyxoma peritonei: a scoping review Pleura and peritoneum, 2025
- Investigation of the putative mechanism by which Ferula sinkiangensis leaves alleviate functional Dyspepsia-like symptoms in rats via modulation of the NO/cGMP/PKG signaling pathway Frontiers in pharmacology, 2026
- Development of pH-Sensitive Multiparticulates for Orally Disintegrating Tablets of Proton Pump Inhibitors: Physicochemical Characterization and Drug Release Studies Pharmaceutics, 2025
- Extraintestinal Clostridioides difficile Infection (CDI): A Recurrent Battle with Resilient Abdominal Wall Abscess European journal of case reports in internal medicine, 2023
- Efficacy, safety and cost-effectiveness of vonoprazan vs Proton Pump Inhibitors in reflux disorders and H. pylori eradication: A literature review Annals of medicine and surgery (2012), 2022
- Mycobacterial respiratory chain enzymes and growth are inhibited by decylubiquinone Communications biology, 2025
- Inhibition mechanism of potential antituberculosis compound lansoprazole sulfide Proceedings of the National Academy of Sciences of the United States of America, 2024
- From esophagus to colon: A narrative review of eosinophilic gastrointestinal disorders World journal of gastrointestinal pathophysiology, 2026
- pH variations enable guanine crystal formation within iridosomes Nature chemical biology, 2026
- Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study Frontiers in pharmacology, 2025
- C-S bond formation through nucleophilic substitution reaction of thiol derivatives with activated aryl halides iScience, 2026
- Proton pump inhibitor use and risk of stroke: A systematic review and meta-analysis Pakistan journal of medical sciences, 2024
- Exploring the mechanisms and targets of proton pump inhibitors-induced osteoporosis through network toxicology, molecular docking, and molecular dynamics simulations Frontiers in pharmacology, 2025
- A Systematic Review of the Adverse Effects of Long-Term Proton Pump Inhibitor Use on the Gastrointestinal System in the Adult Population Cureus, 2025
- Evolution of proton pump inhibitor research in reflux esophagitis: a Web of Science-based global bibliometric assessment [1990-2026] Journal of thoracic disease, 2026
- Herbal and Natural Product Interventions to Modulate Gut Microbiota in Acid Suppression-Associated Dysbiosis: a systematic review protocol Journal of pharmacopuncture, 2026
- A novel nanoparticulate system for sustained delivery of acid-labile lansoprazole Colloids and surfaces. B, Biointerfaces, 2013
- Effect of adsorbents on the absorption of lansoprazole with surfactant International journal of pharmaceutics, 2005
- New gastroprotective labdeneamides from (4S,9R,10R) methyl 18-carboxy-labda-8,13(E)-diene-15-oate Planta medica, 2012
- In vitro study of the variable effects of proton pump inhibitors on voriconazole Antimicrobial agents and chemotherapy, 2015
- Is the Use of Proton-pump Inhibitors a Risk Factor for Alzheimer's Disease? Molecular Mechanisms and Clinical Implications Current medicinal chemistry, 2018
- In vitro interactions of proton pump inhibitors and azoles against pathogenic fungi Frontiers in cellular and infection microbiology, 2024
- In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem The Journal of antimicrobial chemotherapy, 1998
- Efficacy and safety of faropenem in eradication therapy of Helicobacter pylori Helicobacter, 2007
- Gastroprotective activity and cytotoxic effect of cyperenoic acid derivatives The Journal of pharmacy and pharmacology, 2006
- Mechanism of Reductive Metabolism and Chiral Inversion of Proton Pump Inhibitors Drug metabolism and disposition: the biological fate of chemicals, 2019
- Electrophilic and Drug-Induced Stimulation of NOTCH3 N-terminal Fragment Oligomerization in Cerebrovascular Pathology Translational stroke research, 2021
- In vitro and in vivo evaluation of drug-drug interaction between dabigatran and proton pump inhibitors Fundamental & clinical pharmacology, 2015
- Inhibition of lysosomal enzyme activities by proton pump inhibitors Journal of gastroenterology, 2013
- Species differences in micronucleus induction of the clastogenic compounds associated with drug metabolic profile The Journal of toxicological sciences, 2019
- Spondias purpurea L. (Anacardiaceae): Antioxidant and Antiulcer Activities of the Leaf Hexane Extract Oxidative medicine and cellular longevity, 2017
- Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro Arzneimittel-Forschung, 1998
- Gastroprotective effect of the Mapuche crude drug Araucaria araucana resin and its main constituents Journal of ethnopharmacology, 2005
- Class effects of proton pump inhibitors in preventing oxaliplatin-induced peripheral neurotoxicity Journal of pharmacological sciences, 2025
- Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine Circulation, 2013
- Lansoprazole inhibits nitric oxide and prostaglandin E(2) production in murine macrophage RAW 264.7 cells Inflammation, 2012
- Gastroprotective and cytotoxic effect of dehydroabietic acid derivatives Pharmacological research, 2005
- Design and evaluation of jingzhiguanxin monolithic osmotic pump tablet Chemical & pharmaceutical bulletin, 2006
- Proton pump inhibitors induce a caspase-independent antitumor effect against human multiple myeloma Cancer letters, 2016
- Gastroprotective activity of sesquiterpene derivatives from Fabiana imbricata Phytotherapy research : PTR, 2005
- Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells PloS one, 2012
- Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori Microbiology and immunology, 1997
- Unveiling some FDA-approved drugs as inhibitors of the store-operated Ca2+ entry pathway Scientific reports, 2017
- The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p Biochemical pharmacology, 2017
- In-vitro activity of lansoprazole against Helicobacter pylori The Journal of antimicrobial chemotherapy, 1997
- Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability AAPS PharmSciTech, 2014
- Evaluation of selected commercial pharmacotherapeutic drugs as potential pancreatic lipase inhibitors and antiproliferative compounds Drug development research, 2019
- Stereoselective Inhibition of Renal Basolateral Human Organic Anion Transporter 3 by Lansoprazole Enantiomers Pharmacology, 2018
- Clopidogrel, CYP2C19, and a Black Box Journal of clinical pharmacology, 2013
- Lansoprazole and ethanol metabolism: comparison with omeprazole and cimetidine Pharmacology & toxicology, 1997
- Pharmacokinetic differences between lansoprazole enantiomers in rats The Journal of pharmacy and pharmacology, 1998
- In-vitro activity of rabeprazole, lansoprazole, and esomeprazole against Helicobacter pylori Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2003
- Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro Antimicrobial agents and chemotherapy, 1996
- The gastric H,K-ATPase blocker lansoprazole is an inhibitor of chloride channels British journal of pharmacology, 2000
- In vitro activity of clarithromycin against intracellular Helicobacter pylori Antimicrobial agents and chemotherapy, 2001
- In silico and in vitro screening for inhibition of cytochrome P450 CYP3A4 by comedications commonly used by patients with cancer Drug metabolism and disposition: the biological fate of chemicals, 2006
- Gastroprotective activity of a new semi-synthetic solidagenone derivative in mice The Journal of pharmacy and pharmacology, 2005
- Gastroprotective effect and cytotoxicity of labdenamides Planta medica, 2007
- Freeze dried chitosan/ poly-(glutamic acid) microparticles for intestinal delivery of lansoprazole Current drug delivery, 2012
- Gastroprotective effect and cytotoxicity of carnosic acid derivatives Planta medica, 2011
- Proton pump inhibitors reduce interferon-γ-induced neurotoxicity and STAT3 phosphorylation of human astrocytes Glia, 2011
- Selected pharmacotherapy agents as antiproliferative and anti-inflammatory compounds Drug development research, 2020
- The chemotherapeutic effects of H+/K+ inhibitors on Helicobacter pylori infection Pharmacology & therapeutics, 1996
- ATPase inhibitors suppress actinomycin D-induced apoptosis in leukemia cells Anticancer research, 2002
- Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence British journal of cancer, 2002
- Proton pump inhibitors and gastritis Journal of clinical biochemistry and nutrition, 2008
- Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2006
- New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis PLoS pathogens, 2020
- The expression of heme oxygenase-1 induced by lansoprazole Journal of clinical biochemistry and nutrition, 2009
